Landscape of BRCA1 and BRCA2 germline, somatic, and reversion alterations detectable by cell-free DNA testing among patients with metastatic breast, ovarian, pancreatic, or prostate cancer.
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Aditya Bardia, Thereasa A. Rich, Victoria M. Raymond, Stephen R Fairclough, A. Oliver Sartor, Michael B. Lilly, Mohammad Nezami, Sandip Pravin Patel, Benedito A. Carneiro, Alice C. Fan, Adam Brufsky, Barbara A. Parker, Benjamin B. Bridges, Neeraj Agarwal, Benjamin Louis Maughan, Richard B. Lanman, Massimo Cristofanilli
Institutions: Harvard University, Massachusetts General Hospital, Guardant (United States), Tulane University, Medical University of South Carolina, Moores Cancer Center, Brown University, Lifespan, Stanford Cancer Institute, University of Pittsburgh Medical Center, St. Luke's Mountain States Tumor Institute, University of Utah, Huntsman Cancer Institute, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2889931678